Dr Shelley Day Ghafoori, MD | |
801 W 38th St, Suite 200, Austin, TX 78705-1167 | |
(512) 451-0103 | |
(512) 451-2741 |
Full Name | Dr Shelley Day Ghafoori |
---|---|
Gender | Female |
Speciality | Ophthalmology |
Experience | 19 Years |
Location | 801 W 38th St, Austin, Texas |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1588788830 | NPI | - | NPPES |
3127094-03 | Medicaid | TX | |
3127094-01 | Medicaid | TX | |
3127094-02 | Medicaid | TX | |
3127094-04 | Medicaid | TX |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207WX0107X | Ophthalmology - Retina Specialist | P4858 (Texas) | Secondary |
207W00000X | Ophthalmology | P4858 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Ascension Seton Medical Center Austin | Austin, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Austin Retina Associates Pllc | 2163497801 | 12 |
News Archive
Researchers at the California Institute of Technology have developed an autonomous molecular machine comprising a single strand of DNA that can move around, collect specific molecules and sort them into predefined locations. Furthermore, this nanobot has been designed in such a way that requires no external source of energy or instruction.
MicroStockProfit.com announces an investment report featuring Osiris Therapeutics Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
Whitehead Institute researchers have redefined the function of a gene whose mutation causes Rett syndrome, a neurodevelopmental autism spectrum disorder. This new research offers an improved understanding of the defects found in the neurons of Rett syndrome patients and could lead to novel therapies for the disease.
Researchers at the University of Maryland School of Medicine (UMSOM) have received a $5 million federal grant to pool genomic information from existing and new datasets - predominantly in African and African American populations - in order to calculate the risk of developing specific diseases.
Bristol-Myers Squibb Company today announced that new data from studies investigating its immunotherapies in adjuvant and advanced melanoma, non-small cell lung cancer (NSCLC) and metastatic renal cell carcinoma (mRCC) will be presented at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago from May 30-June 3.
› Verified 5 days ago
Entity Name | Austin Retina Associates Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1033183561 PECOS PAC ID: 2163497801 Enrollment ID: O20040827000054 |
News Archive
Researchers at the California Institute of Technology have developed an autonomous molecular machine comprising a single strand of DNA that can move around, collect specific molecules and sort them into predefined locations. Furthermore, this nanobot has been designed in such a way that requires no external source of energy or instruction.
MicroStockProfit.com announces an investment report featuring Osiris Therapeutics Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
Whitehead Institute researchers have redefined the function of a gene whose mutation causes Rett syndrome, a neurodevelopmental autism spectrum disorder. This new research offers an improved understanding of the defects found in the neurons of Rett syndrome patients and could lead to novel therapies for the disease.
Researchers at the University of Maryland School of Medicine (UMSOM) have received a $5 million federal grant to pool genomic information from existing and new datasets - predominantly in African and African American populations - in order to calculate the risk of developing specific diseases.
Bristol-Myers Squibb Company today announced that new data from studies investigating its immunotherapies in adjuvant and advanced melanoma, non-small cell lung cancer (NSCLC) and metastatic renal cell carcinoma (mRCC) will be presented at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago from May 30-June 3.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Shelley Day Ghafoori, MD 801 W 38th St, Suite 200, Austin, TX 78705-1167 Ph: (512) 451-0103 | Dr Shelley Day Ghafoori, MD 801 W 38th St, Suite 200, Austin, TX 78705-1167 Ph: (512) 451-0103 |
News Archive
Researchers at the California Institute of Technology have developed an autonomous molecular machine comprising a single strand of DNA that can move around, collect specific molecules and sort them into predefined locations. Furthermore, this nanobot has been designed in such a way that requires no external source of energy or instruction.
MicroStockProfit.com announces an investment report featuring Osiris Therapeutics Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
Whitehead Institute researchers have redefined the function of a gene whose mutation causes Rett syndrome, a neurodevelopmental autism spectrum disorder. This new research offers an improved understanding of the defects found in the neurons of Rett syndrome patients and could lead to novel therapies for the disease.
Researchers at the University of Maryland School of Medicine (UMSOM) have received a $5 million federal grant to pool genomic information from existing and new datasets - predominantly in African and African American populations - in order to calculate the risk of developing specific diseases.
Bristol-Myers Squibb Company today announced that new data from studies investigating its immunotherapies in adjuvant and advanced melanoma, non-small cell lung cancer (NSCLC) and metastatic renal cell carcinoma (mRCC) will be presented at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago from May 30-June 3.
› Verified 5 days ago
Dr. Kristen Michelle Hawthorne, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2610 S Ih 35, Austin, TX 78704 Phone: 512-443-9715 Fax: 512-443-9845 | |
Saradha Chexal, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3705 Medical Pkwy Ste 460, Austin, TX 78705 Phone: 512-454-5851 | |
Dr. John David Fisher, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2901 Montopolis Dr, Austin, TX 78741 Phone: 512-389-6571 Fax: 512-389-6511 | |
Dr. Clio Armitage Harper Iii, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 801 W 38th St, Suite 200, Austin, TX 78705 Phone: 512-451-0103 Fax: 512-451-2741 | |
Dr. Nadja Ivette Torres, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2610 S Ih 35, Austin, TX 78704 Phone: 512-443-9715 Fax: 512-443-9845 | |
Fuad Makkouk, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 9707 Anderson Mill Rd Ste 230, Austin, TX 78750 Phone: 512-693-9363 | |
Irina Volosko, DO Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3410 Far West Blvd Ste 140, Austin, TX 78731 Phone: 512-427-1107 Fax: 512-427-1207 |